Sandip Kapadia

Board Member at VectivBio

Sandip Kapadia, MBA, CPA, has served as a member of our board of directors since October 2020. Mr. Kapadia brings nearly 25 years of life science industry experience and is currently the Chief Financial Officer for Harmony Biosciences. Previously, Mr. Kapadia was CFO of Intercept Pharmaceuticals from 2016-2021 and held numerous financial leadership positions over 19 years at Novartis and Novartis affiliates in the United States, Switzerland, the Netherlands, and the United Kingdom, including CFO of North America at Novartis’s generic division, Sandoz. Mr. Kapadia is currently also a director of Passage Bio and Molecular Partners AG, and previously of Therachon AG. Mr. Kapadia received a B.S. in Accounting from Montclair State University and an M.B.A. from Rutgers University and is also a U.S. Certified Public Accountant.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


VectivBio

VectivBio AG is a global biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases.


Industries

Headquarters

Basel, Switzerland

Employees

11-50

Links